Search Results - Jungnelius, Jarl Ulf

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Abstract CT092: Clinical outcome and safety in patients with microsatellite-stable, metastatic colorectal or pancreatic cancer treated with the CXCL12 inhibitor NOX-A12 in combination with PD-1 checkpoint inhibitor pembrolizumab

    Abstract CT092: Clinical outcome and safety in patients with microsatellite-stable, metastatic colorectal or pancreatic cancer treated with the CXCL12 inhibitor NOX-A12 in combinat... by Halama, Niels, Pruefer, Ulrike, Froemming, Anna, Beyer, Diana, Eulberg, Dirk, Jungnelius, Jarl Ulf, Mangasarian, Aram

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Abstract CT117: Phase 1/2 study with CXCL12 inhibitor NOX-A12 and pembrolizumab in patients with microsatellite-stable, metastatic colorectal or pancreatic cancer

    Abstract CT117: Phase 1/2 study with CXCL12 inhibitor NOX-A12 and pembrolizumab in patients with microsatellite-stable, metastatic colorectal or pancreatic cancer by Halama, Niels, Williams, Anja, Prüfer, Ulrike, Frömming, Anna, Beyer, Diana, Eulberg, Dirk, Jungnelius, Jarl Ulf, Mangasarian, Aram

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Abstract B206: Evaluation of tumor biomarkers in patients with microsatellite-stable, metastatic colorectal or pancreatic cancer treated with the CXCL12 inhibitor NOX-A12 and preliminary safety in combination with PD-1 checkpoint inhibitor pembrolizumab

    Abstract B206: Evaluation of tumor biomarkers in patients with microsatellite-stable, metastatic colorectal or pancreatic cancer treated with the CXCL12 inhibitor NOX-A12 and preli... by Halama, Niels, Prüfer, Ulrike, Froemming, Anna, Beyer, Diana, Eulberg, Dirk, Jungnelius, Jarl Ulf, Mangasarian, Aram

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: